Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the Cellular and Molecular Mechanism of Discoidin Domain Receptors (DDR1 and DDR2) in Bone Formation, Regeneration, and Its Associated Disease Conditions. | Int J Mol Sci | 2023 | 37834343 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Cisplatin, Cannabidiol, and Intermittent Serum Starvation Alone and in Various Combinations on Colorectal Cancer Cells. | Int J Mol Sci | 2023 | 37834191 | PubTator, text mining | PubMed |
| Involvement of Epithelial-Mesenchymal Transition (EMT) in Autoimmune Diseases. | Int J Mol Sci | 2023 | 37833928 | PubTator, text mining | PubMed |
| Integrative analysis of cancer-associated fibroblast signature in gastric cancer. | Heliyon | 2023 | 37809716 | PubTator, text mining | PubMed |
| The role of cancer-associated fibroblasts in bladder cancer progression. | Heliyon | 2023 | 37809511 | PubTator, text mining | PubMed |
| Osteonectin bidirectionally regulates osteoblast mineralization. | J Orthop Surg Res | 2023 | 37807073 | PubTator, text mining | PubMed |
| Obesity accelerates endothelial-to-mesenchymal transition in adipose tissues of mice and humans. | Front Cardiovasc Med | 2023 | 37795485 | PubTator, text mining | PubMed |
| Kisspeptin-mediated improvement of sensitivity to BRAF inhibitors in vemurafenib-resistant melanoma cells. | Front Oncol | 2023 | 37790750 | PubTator, text mining | PubMed |
| Research on the Influence of MUVON PLUS Treatment Upon the Biomechanical Behavior of the Human Osteoarthritic Knee. | Curr Health Sci J | 2023 | 37786768 | PubTator, text mining | PubMed |
| Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. | Mol Cancer | 2023 | 37784082 | PubTator, text mining | PubMed |
| EGFR Mutation Detection in Brazilian Patients With Non-Small-Cell Lung Cancer: Lessons From Real-World Data Scenario of Molecular Testing. | JCO Glob Oncol | 2023 | 37769218 | PubTator, text mining | PubMed |
| Advantages of photo-curable collagen-based cell-laden bioinks compared to methacrylated gelatin (GelMA) in digital light processing (DLP) and extrusion bioprinting. | Mater Today Bio | 2023 | 37766893 | PubTator, text mining | PubMed |
| Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers. | Int J Mol Sci | 2023 | 37762559 | PubTator, text mining | PubMed |
| Effects of EGFR driver mutations on pathologic regression in resectable locally advanced non-small cell lung cancer treated with neoadjuvant chemoradiation and completion surgery. | Br J Radiol | 2023 | 37751214 | PubTator, text mining | PubMed |
| Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients. | Nat Commun | 2023 | 37749078 | PubTator, text mining | PubMed |
| Prognostic significance of TP53 and PIK3CA mutations analyzed by next-generation sequencing in breast cancer. | Medicine (Baltimore) | 2023 | 37747019 | PubTator, text mining | PubMed |
| The role of breastfeeding in breast cancer prevention: a literature review. | Front Oncol | 2023 | 37746260 | PubTator, text mining | PubMed |
| miRNA and mRNA Signatures in Human Acute Kidney Injury Tissue. | bioRxiv | 2023 | 37745313 | PubTator, text mining | PubMed |
| Transcriptomic analysis identifies four novel receptors potentially linking endometrial cancer with polycystic ovary syndrome and generates a transcriptomic atlas. | Oncotarget | 2023 | 37737665 | PubTator, text mining | PubMed |
| Multidimensional computational study to understand non-coding RNA interactions in breast cancer metastasis. | Sci Rep | 2023 | 37737288 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=11